Abstract
The fluorinated hydrocarbons that are used for anesthesia are derived from ether. Although they have many benefits, there are several side effects of these drugs, including untoward hepatic effects. Whether the use of halothane gas can be revitalized is unknown. Introducing nanocarriers inside the halothane molecule can increase its benefits as an anesthetic in the lungs and cardiovascular system and prevent exposure to the liver. The findings of new fields, such as cancer therapy, and anesthetic agents, such as propofol, can improve the quality of the drug using nanomedicine.
- Implication for health policy/practice/research/medical education:
Halothane is an inhalational anesthetic agent with multiple benefits, but an important untoward effect. There is a chance for producing this drug with the newly proposed nanotechnology. Regarding its financial benefits, it is commonly used until producing the new generation of any other anesthetic drug. - Please cite this paper as:
Dabbagh A, Rajaei S. Halothane: Is there still any place for using the gas as an anesthetic? Hepat Mon. 2011;11(7):511-2.
© 2011 Kowsar M.P.Co. All rights reserved.
Keywords
Full Text
Full text is available in PDF
Copyright
© 0, Author(s). This open-access article is available under the Creative Commons Attribution 4.0 (CC BY 4.0) International License (https://creativecommons.org/licenses/by/4.0/), which allows for unrestricted use, distribution, and reproduction in any medium, provided that the original work is properly cited.